Author

Zhihai Li

Chinese Academy of SciencesORCID 0000-0002-2816-6243Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Molecular Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:drug response / drug discovery· 1 Approach:experimental assay· 1

Frequent Co-Authors

Erli You· 1 shared Fulai ZhouiD· 1 shared Gengfu XiaoiD· 1 shared H. Eric XuiD· 1 shared Hualiang JiangiD· 1 shared Jingjing ShiiD· 1 shared Leike ZhangiD· 1 shared Mingliang LiuiD· 1 shared

Activity by Year

2020-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMolecular Biology

Erli You

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Structural basis for repurposing a 100-years-old drug suramin for treating COVID-19

Wanchao Yin, Xiaodong Luan, Zhihai Li, Leike Zhang, Ziwei Zhou, Minqi Gao, Xiaoxi Wang, Fulai Zhou, Jingjing Shi, Erli You, Mingliang Liu, Qingxia Wang, Qingxing Wang, Yi Jiang, Hualiang Jiang, , H. Eric Xu

The paper discovers suramin as a potent inhibitor of SARS-CoV-2 RNA polymerase and provides its structural mechanism for repurposing in treating COVID-19.

bioRxiv · Oct 6, 2020 · PreprintMolecular Biology